| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | structural constituent of cytoskeleton | 1.48e-05 | 130 | 81 | 6 | GO:0005200 | |
| GeneOntologyBiologicalProcess | endomembrane system organization | ATP8B4 GBF1 MAPK15 LMNB1 MYO5A SPTB TJAP1 PRKCD FHIP1B STX11 TMCC1 TMED3 | 1.33e-05 | 672 | 82 | 12 | GO:0010256 |
| GeneOntologyCellularComponent | polymeric cytoskeletal fiber | KNTC1 DST LMNB1 MYO5A SYNM DSP ACTBL2 DNAI7 CCDC57 CSPP1 TUBAL3 TBCA DNAH11 KPTN | 9.65e-06 | 899 | 82 | 14 | GO:0099513 |
| GeneOntologyCellularComponent | supramolecular fiber | KNTC1 COL6A3 DST LMNB1 MYO5A SYNM DSP ACTBL2 DNAI7 CCDC57 CSPP1 TUBAL3 TBCA DNAH11 KPTN | 4.79e-05 | 1179 | 82 | 15 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | KNTC1 COL6A3 DST LMNB1 MYO5A SYNM DSP ACTBL2 DNAI7 CCDC57 CSPP1 TUBAL3 TBCA DNAH11 KPTN | 5.18e-05 | 1187 | 82 | 15 | GO:0099081 |
| Domain | TEX28/TMCC | 1.08e-04 | 4 | 80 | 2 | IPR019394 | |
| Domain | Tmemb_cc2 | 1.08e-04 | 4 | 80 | 2 | PF10267 | |
| Domain | tRNA-bd_arm | 1.44e-04 | 24 | 80 | 3 | IPR010978 | |
| Domain | Spectrin_repeat | 2.55e-04 | 29 | 80 | 3 | IPR002017 | |
| Domain | - | 2.69e-04 | 6 | 80 | 2 | 3.90.1290.10 | |
| Domain | Spectrin/alpha-actinin | 3.43e-04 | 32 | 80 | 3 | IPR018159 | |
| Domain | SPEC | 3.43e-04 | 32 | 80 | 3 | SM00150 | |
| Domain | Plectin_repeat | 3.75e-04 | 7 | 80 | 2 | IPR001101 | |
| Domain | Plectin | 3.75e-04 | 7 | 80 | 2 | PF00681 | |
| Domain | PLEC | 3.75e-04 | 7 | 80 | 2 | SM00250 | |
| Domain | Cadherin_C | 7.70e-04 | 42 | 80 | 3 | IPR032455 | |
| Domain | Cadherin_C_2 | 7.70e-04 | 42 | 80 | 3 | PF16492 | |
| Domain | HAT | 7.97e-04 | 10 | 80 | 2 | IPR003107 | |
| Domain | HAT | 7.97e-04 | 10 | 80 | 2 | SM00386 | |
| Domain | TPR_8 | 1.52e-03 | 53 | 80 | 3 | PF13181 | |
| Domain | - | 1.83e-03 | 15 | 80 | 2 | 1.10.1000.11 | |
| Domain | Sec7 | 1.83e-03 | 15 | 80 | 2 | PF01369 | |
| Domain | Sec7_alpha_orthog | 1.83e-03 | 15 | 80 | 2 | IPR023394 | |
| Domain | Sec7 | 2.09e-03 | 16 | 80 | 2 | SM00222 | |
| Domain | GGL | 2.09e-03 | 16 | 80 | 2 | SM00224 | |
| Domain | G-gamma | 2.09e-03 | 16 | 80 | 2 | PF00631 | |
| Domain | - | 2.09e-03 | 16 | 80 | 2 | 4.10.260.10 | |
| Domain | Gprotein-gamma | 2.09e-03 | 16 | 80 | 2 | IPR001770 | |
| Domain | G_PROTEIN_GAMMA | 2.09e-03 | 16 | 80 | 2 | PS50058 | |
| Domain | SEC7 | 2.09e-03 | 16 | 80 | 2 | PS50190 | |
| Domain | Sec7_dom | 2.09e-03 | 16 | 80 | 2 | IPR000904 | |
| Domain | Actin_CS | 2.09e-03 | 16 | 80 | 2 | IPR004001 | |
| Domain | G-protein_gamma-like_dom | 2.09e-03 | 16 | 80 | 2 | IPR015898 | |
| Domain | ACTINS_2 | 2.36e-03 | 17 | 80 | 2 | PS00432 | |
| Domain | Cadherin_2 | 2.73e-03 | 65 | 80 | 3 | PF08266 | |
| Domain | Cadherin_N | 2.73e-03 | 65 | 80 | 3 | IPR013164 | |
| Domain | - | 3.96e-03 | 22 | 80 | 2 | 1.10.196.10 | |
| Domain | DEP | 3.96e-03 | 22 | 80 | 2 | PF00610 | |
| Domain | DEP | 3.96e-03 | 22 | 80 | 2 | PS50186 | |
| Domain | RGS_subdom1 | 3.96e-03 | 22 | 80 | 2 | IPR024066 | |
| Domain | DEP | 3.96e-03 | 22 | 80 | 2 | SM00049 | |
| Domain | Actinin_actin-bd_CS | 4.32e-03 | 23 | 80 | 2 | IPR001589 | |
| Domain | DEP_dom | 4.32e-03 | 23 | 80 | 2 | IPR000591 | |
| Domain | Spectrin | 4.32e-03 | 23 | 80 | 2 | PF00435 | |
| Domain | ACTININ_2 | 4.32e-03 | 23 | 80 | 2 | PS00020 | |
| Domain | ACTININ_1 | 4.32e-03 | 23 | 80 | 2 | PS00019 | |
| Domain | Leu-rich_rpt_typical-subtyp | 7.05e-03 | 177 | 80 | 4 | IPR003591 | |
| Domain | LRR_TYP | 7.05e-03 | 177 | 80 | 4 | SM00369 | |
| Domain | Actin | 7.77e-03 | 31 | 80 | 2 | IPR004000 | |
| Domain | Actin | 7.77e-03 | 31 | 80 | 2 | PF00022 | |
| Domain | ACTIN | 7.77e-03 | 31 | 80 | 2 | SM00268 | |
| Pubmed | 5.04e-08 | 4 | 82 | 3 | 22371490 | ||
| Pubmed | 1.05e-06 | 9 | 82 | 3 | 10339615 | ||
| Pubmed | KNTC1 RAD51AP1 AP1AR DST LMNB1 MYO5A DSP PCDHGA6 PCDHGA5 PPFIA2 ACTBL2 CNTRL PRPF6 CCDC57 HNRNPR | 1.25e-06 | 1442 | 82 | 15 | 35575683 | |
| Pubmed | 2.52e-06 | 493 | 82 | 9 | 15368895 | ||
| Pubmed | 3.68e-06 | 98 | 82 | 5 | 34943047 | ||
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 29053101 | ||
| Pubmed | E2-EPF UCP Possesses E3 Ubiquitin Ligase Activity via Its Cysteine 118 Residue. | 5.49e-06 | 2 | 82 | 2 | 27685940 | |
| Pubmed | The von Hippel-Lindau tumour-suppressor protein interaction with protein kinase Cdelta. | 5.49e-06 | 2 | 82 | 2 | 16669786 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | DST LMNB1 MYO5A SYNM DSP ACTBL2 MCM3 PRPF6 TRIM27 NUP160 GTF3C3 XAB2 HNRNPR | 7.43e-06 | 1257 | 82 | 13 | 36526897 |
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | GBF1 LMNB1 COQ8A DSP ECHDC1 INTS1 MCM3 GNB4 PRPF6 TRIM27 NUP160 GTF3C3 HNRNPR | 7.43e-06 | 1257 | 82 | 13 | 37317656 |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | PPP1R7 SETX DST LMNB1 DSP PPFIA2 PCDHB14 INTS1 MAGEB6 HNRNPR | 9.20e-06 | 736 | 82 | 10 | 29676528 |
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | VHL PPP1R7 KNTC1 GBF1 DSP MCM3 FRYL PRPF6 SPOP NUP160 GTF3C3 HNRNPR KPTN | 9.32e-06 | 1284 | 82 | 13 | 17353931 |
| Pubmed | Widespread Expansion of Protein Interaction Capabilities by Alternative Splicing. | VHL SETX FBXO8 ODAD1 TMCC2 SLC22A15 MCM3 TRIM27 STX11 CCDC57 | 9.87e-06 | 742 | 82 | 10 | 26871637 |
| Pubmed | 1.00e-05 | 18 | 82 | 3 | 26674342 | ||
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | VHL SETX DST VPS72 LMNB1 DSP ACTR5 INTS1 PRPF6 TRIM27 MXD4 XAB2 HNRNPR | 1.01e-05 | 1294 | 82 | 13 | 30804502 |
| Pubmed | 1.07e-05 | 446 | 82 | 8 | 24255178 | ||
| Pubmed | 1.45e-05 | 334 | 82 | 7 | 30425250 | ||
| Pubmed | 1.47e-05 | 777 | 82 | 10 | 35844135 | ||
| Pubmed | 1.64e-05 | 3 | 82 | 2 | 24755289 | ||
| Pubmed | Von Hippel-Lindau regulates interleukin-32β stability in ovarian cancer cells. | 1.64e-05 | 3 | 82 | 2 | 29050245 | |
| Pubmed | 1.64e-05 | 3 | 82 | 2 | 8838817 | ||
| Pubmed | 1.64e-05 | 3 | 82 | 2 | 30903204 | ||
| Pubmed | The von hippel-lindau protein suppresses androgen receptor activity. | 1.64e-05 | 3 | 82 | 2 | 24422631 | |
| Pubmed | 1.64e-05 | 3 | 82 | 2 | 10521509 | ||
| Pubmed | Dynamics of Lamins B and A/C and Nucleoporin Nup160 during Meiotic Maturation in Mouse Oocytes. | 1.64e-05 | 3 | 82 | 2 | 28374669 | |
| Pubmed | 2.35e-05 | 652 | 82 | 9 | 31180492 | ||
| Pubmed | 2.38e-05 | 653 | 82 | 9 | 22586326 | ||
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | KNTC1 ATP8B4 GBF1 MAPK15 LMNB1 DSP PRKCD MCM3 PRPF6 COASY NUP160 GTF3C3 HNRNPR | 2.79e-05 | 1425 | 82 | 13 | 30948266 |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | DST LMNB1 MYO5A DSP ACTBL2 INTS1 MCM3 PRPF6 NUP160 XAB2 HNRNPR | 2.84e-05 | 1024 | 82 | 11 | 24711643 |
| Pubmed | The Daam2-VHL-Nedd4 axis governs developmental and regenerative oligodendrocyte differentiation. | 3.28e-05 | 4 | 82 | 2 | 32792353 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | MYO5A COQ8A PPFIA2 ANXA4 SPTB GAS6 TMEM63C TJAP1 ANKRD24 FRYL CAMTA1 CCDC57 TMCC1 | 4.38e-05 | 1489 | 82 | 13 | 28611215 |
| Pubmed | The ubiquitin-dependent ATPase p97 removes cytotoxic trapped PARP1 from chromatin. | 4.58e-05 | 400 | 82 | 7 | 35013556 | |
| Pubmed | PITHD1 DST VPS72 MYO5A SYNM DSP SPTB RNF38 DAAM2 ANKRD24 DNAI7 XAB2 | 4.68e-05 | 1285 | 82 | 12 | 35914814 | |
| Pubmed | 5.47e-05 | 5 | 82 | 2 | 18780286 | ||
| Pubmed | 5.47e-05 | 5 | 82 | 2 | 22689652 | ||
| Pubmed | 5.47e-05 | 5 | 82 | 2 | 21233420 | ||
| Pubmed | CCT3 acts upstream of YAP and TFCP2 as a potential target and tumour biomarker in liver cancer. | 6.32e-05 | 288 | 82 | 6 | 31501420 | |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | PPP1R7 GBF1 DST MYO5A DSP ACTBL2 MCM3 PRPF6 GTF3C3 TBCA HNRNPR | 8.00e-05 | 1149 | 82 | 11 | 35446349 |
| Pubmed | MCM proteins are negative regulators of hypoxia-inducible factor 1. | 8.19e-05 | 6 | 82 | 2 | 21658608 | |
| Pubmed | 8.19e-05 | 6 | 82 | 2 | 24790204 | ||
| Pubmed | 8.19e-05 | 6 | 82 | 2 | 15897264 | ||
| Pubmed | 8.31e-05 | 187 | 82 | 5 | 26460568 | ||
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | PPP1R7 KNTC1 LMNB1 ANXA4 GNB4 PRPF6 PIBF1 NUP160 GTF3C3 XAB2 HNRNPR | 8.37e-05 | 1155 | 82 | 11 | 20360068 |
| Pubmed | 9.11e-05 | 604 | 82 | 8 | 38803224 | ||
| Pubmed | 1.14e-04 | 7 | 82 | 2 | 32328410 | ||
| Pubmed | 1.14e-04 | 7 | 82 | 2 | 11901153 | ||
| Pubmed | 1.14e-04 | 7 | 82 | 2 | 9679146 | ||
| Pubmed | Identification of novel cadherins expressed in human melanoma cells. | 1.14e-04 | 7 | 82 | 2 | 9182820 | |
| Pubmed | Molecular Characterization of the Oncogene BTF3 and Its Targets in Colorectal Cancer. | 1.17e-04 | 626 | 82 | 8 | 33644029 | |
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | 1.19e-04 | 202 | 82 | 5 | 33005030 | |
| Pubmed | Profiling of Parkin-binding partners using tandem affinity purification. | 1.22e-04 | 203 | 82 | 5 | 24244333 | |
| Pubmed | 1.33e-04 | 638 | 82 | 8 | 33239621 | ||
| Pubmed | Transmembrane and coiled-coil domain family 1 is a novel protein of the endoplasmic reticulum. | 1.52e-04 | 8 | 82 | 2 | 24454821 | |
| Pubmed | 1.67e-04 | 660 | 82 | 8 | 32780723 | ||
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | 1.82e-04 | 853 | 82 | 9 | 28718761 | |
| Pubmed | HENA, heterogeneous network-based data set for Alzheimer's disease. | 1.92e-04 | 120 | 82 | 4 | 31413325 | |
| Pubmed | 1.96e-04 | 9 | 82 | 2 | 12482924 | ||
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | 2.29e-04 | 1082 | 82 | 10 | 38697112 | |
| Pubmed | 2.36e-04 | 234 | 82 | 5 | 36243803 | ||
| Pubmed | Generation and analysis of 280,000 human expressed sequence tags. | 2.40e-04 | 368 | 82 | 6 | 8889549 | |
| Pubmed | Evolution of the regulators of G-protein signaling multigene family in mouse and human. | 2.42e-04 | 51 | 82 | 3 | 11829488 | |
| Pubmed | 2.68e-04 | 131 | 82 | 4 | 34551306 | ||
| Pubmed | 2.87e-04 | 244 | 82 | 5 | 30349055 | ||
| Pubmed | 2.92e-04 | 134 | 82 | 4 | 24324551 | ||
| Pubmed | 2.98e-04 | 11 | 82 | 2 | 12802069 | ||
| Pubmed | 3.09e-04 | 136 | 82 | 4 | 21280222 | ||
| Pubmed | 3.21e-04 | 250 | 82 | 5 | 33536335 | ||
| Pubmed | 3.27e-04 | 390 | 82 | 6 | 17643375 | ||
| Pubmed | 3.29e-04 | 551 | 82 | 7 | 34728620 | ||
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | SETX DST LMNB1 MYO5A DSP PRKCD MCM3 PRPF6 NUP160 GTF3C3 HNRNPR | 3.30e-04 | 1353 | 82 | 11 | 29467282 |
| Pubmed | Protein interactome reveals converging molecular pathways among autism disorders. | 3.62e-04 | 560 | 82 | 7 | 21653829 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | 4.14e-04 | 954 | 82 | 9 | 36373674 | |
| Pubmed | 4.21e-04 | 13 | 82 | 2 | 32073997 | ||
| Pubmed | Analysis of the human E2 ubiquitin conjugating enzyme protein interaction network. | 4.37e-04 | 149 | 82 | 4 | 19549727 | |
| Pubmed | 4.59e-04 | 151 | 82 | 4 | 17043677 | ||
| Pubmed | The Tumor Suppressor CIC Directly Regulates MAPK Pathway Genes via Histone Deacetylation. | 4.61e-04 | 583 | 82 | 7 | 29844126 | |
| Pubmed | 4.71e-04 | 272 | 82 | 5 | 31010829 | ||
| Pubmed | Repression of rRNA transcription by PARIS contributes to Parkinson's disease. | 4.71e-04 | 272 | 82 | 5 | 25315684 | |
| Pubmed | 4.91e-04 | 14 | 82 | 2 | 30542119 | ||
| Pubmed | 4.91e-04 | 14 | 82 | 2 | 27593939 | ||
| Pubmed | Destabilizing NEK2 overcomes resistance to proteasome inhibition in multiple myeloma. | 5.43e-04 | 67 | 82 | 3 | 29863498 | |
| Pubmed | 5.58e-04 | 159 | 82 | 4 | 34537242 | ||
| Pubmed | 5.65e-04 | 15 | 82 | 2 | 14996723 | ||
| Pubmed | 5.65e-04 | 15 | 82 | 2 | 35977942 | ||
| Pubmed | Comparative DNA sequence analysis of mouse and human protocadherin gene clusters. | 5.67e-04 | 68 | 82 | 3 | 11230163 | |
| Pubmed | 5.82e-04 | 285 | 82 | 5 | 34369648 | ||
| Pubmed | 6.10e-04 | 288 | 82 | 5 | 23383273 | ||
| Pubmed | Low BACH2 Expression Predicts Adverse Outcome in Chronic Lymphocytic Leukaemia. | 6.17e-04 | 70 | 82 | 3 | 35008187 | |
| Pubmed | 6.18e-04 | 803 | 82 | 8 | 36517590 | ||
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | 6.38e-04 | 807 | 82 | 8 | 30575818 | |
| Pubmed | Genome-wide generation and systematic phenotyping of knockout mice reveals new roles for many genes. | 6.45e-04 | 16 | 82 | 2 | 23870131 | |
| Pubmed | 6.70e-04 | 72 | 82 | 3 | 34882091 | ||
| Pubmed | Exome sequencing reveals pathogenic mutations in 91 strains of mice with Mendelian disorders. | 6.70e-04 | 72 | 82 | 3 | 25917818 | |
| Pubmed | A striking organization of a large family of human neural cadherin-like cell adhesion genes. | 6.70e-04 | 72 | 82 | 3 | 10380929 | |
| Pubmed | 6.75e-04 | 622 | 82 | 7 | 14574404 | ||
| Pubmed | Cadherin superfamily genes: functions, genomic organization, and neurologic diversity. | 7.26e-04 | 74 | 82 | 3 | 10817752 | |
| Pubmed | A functional screen to identify novel effectors of hematopoietic stem cell activity. | 7.30e-04 | 17 | 82 | 2 | 19379700 | |
| Pubmed | Congenital Muscular Dystrophy Overview – RETIRED CHAPTER, FOR HISTORICAL REFERENCE ONLY | 7.30e-04 | 17 | 82 | 2 | 20301468 | |
| Pubmed | 7.30e-04 | 17 | 82 | 2 | 19376773 | ||
| Pubmed | Rearrangement of the Protein Phosphatase 1 Interactome During Heart Failure Progression. | 7.81e-04 | 174 | 82 | 4 | 29669786 | |
| Interaction | DISC1 interactions | 9.38e-06 | 429 | 82 | 10 | int:DISC1 | |
| Interaction | PRPF18 interactions | 9.51e-06 | 120 | 82 | 6 | int:PRPF18 | |
| Interaction | GOLGA1 interactions | 9.72e-06 | 183 | 82 | 7 | int:GOLGA1 | |
| GeneFamily | Transmembrane and coiled-coil domain containing | 2.43e-05 | 3 | 52 | 2 | 774 | |
| GeneFamily | EF-hand domain containing|Plakins | 2.25e-04 | 8 | 52 | 2 | 939 | |
| GeneFamily | Clustered protocadherins | 8.26e-04 | 64 | 52 | 3 | 20 | |
| GeneFamily | Regulators of G-protein signaling | 1.65e-03 | 21 | 52 | 2 | 720 | |
| Coexpression | PUJANA_XPRSS_INT_NETWORK | 1.48e-05 | 168 | 82 | 6 | M18811 | |
| Coexpression | GSE13547_CTRL_VS_ANTI_IGM_STIM_BCELL_12H_UP | 2.72e-05 | 187 | 82 | 6 | M2984 | |
| Coexpression | GSE14308_TH1_VS_TH17_DN | 3.96e-05 | 200 | 82 | 6 | M3374 | |
| Coexpression | GSE3982_MAST_CELL_VS_TH2_DN | 3.96e-05 | 200 | 82 | 6 | M5456 | |
| Coexpression | BRUINS_UVC_RESPONSE_LATE | COL6A3 FBXO8 LMNB1 MYO5A ECHDC1 SLC22A15 RNF38 MCM3 DAAM2 SPOP COASY RGS7 TSPAN5 | 4.92e-05 | 1136 | 82 | 13 | M2247 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | SETX GBF1 DST LMNB1 FRYL SPOP PIBF1 TMCC1 NUP160 RGS7 TSPAN5 | 7.15e-05 | 856 | 82 | 11 | M4500 |
| Coexpression | BRUINS_UVC_RESPONSE_LATE | COL6A3 FBXO8 LMNB1 MYO5A ECHDC1 SLC22A15 RNF38 MCM3 DAAM2 SPOP COASY RGS7 TSPAN5 | 8.43e-05 | 1198 | 82 | 13 | MM1062 |
| Coexpression | BROWNE_HCMV_INFECTION_24HR_DN | 9.37e-05 | 145 | 82 | 5 | M14098 | |
| Coexpression | VANDESLUIS_NORMAL_EMBRYOS_UP | 9.61e-05 | 5 | 82 | 2 | MM908 | |
| Coexpression | VANDESLUIS_NORMAL_EMBRYOS_UP | 9.61e-05 | 5 | 82 | 2 | M2303 | |
| Coexpression | MARKEY_RB1_ACUTE_LOF_UP | 1.01e-04 | 237 | 82 | 6 | M15606 | |
| Coexpression | MARKEY_RB1_ACUTE_LOF_UP | 1.08e-04 | 240 | 82 | 6 | MM976 | |
| ToppCell | Multiple_Sclerosis-Other-RBC|Multiple_Sclerosis / Disease, Lineage and Cell Type | 9.94e-07 | 179 | 82 | 6 | 15763dc59ee6186416e203ffbb450ae4608eba59 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Epithelial-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.17e-06 | 184 | 82 | 6 | 264e14aa1859cfc0ed5fb40e97ea189aed9ef4a5 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Epithelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.17e-06 | 184 | 82 | 6 | d7eccbd21c480d907fdc8eff2bf5ae22ae452221 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Epithelial-neuroepithelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.17e-06 | 184 | 82 | 6 | 22010cfe0428ebfa40952cc1a1a12ad3d25b35c9 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.59e-06 | 194 | 82 | 6 | 4a2c127c90d1fefe604fcb9e796577d21b489dd6 | |
| ToppCell | moderate-Epithelial-Ciliated|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.63e-06 | 195 | 82 | 6 | e80f5cdf0b18066b3e6c2f5452e58f101c67932c | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.73e-06 | 197 | 82 | 6 | 74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9 | |
| ToppCell | MS-Multiple_Sclerosis-Others-RBC|Multiple_Sclerosis / Disease, condition lineage and cell class | 1.84e-06 | 199 | 82 | 6 | b9e7549f67bc33284bacf9a160b3916651659809 | |
| ToppCell | Tracheal-10x5prime-Stromal-Myofibroblastic-Muscle_smooth_systemic_arterial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.84e-06 | 199 | 82 | 6 | c2903b1a4b91e94bbdaa909bacefe901255cf248 | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-FOXM1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.84e-06 | 199 | 82 | 6 | 98575fcce726589e93fbb4df1aab03e57cb56076 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-FOXM1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.84e-06 | 199 | 82 | 6 | be2276c9a1994579ba1d2998b49bf549c1324d44 | |
| ToppCell | Control_saline-Endothelial-Endothelial-FOXM1|Control_saline / Treatment groups by lineage, cell group, cell type | 1.89e-06 | 200 | 82 | 6 | 9bbc7b5561151f6ff65f40b3226271def732e5d9 | |
| ToppCell | Healthy_donor-RBC|Healthy_donor / disease group, cell group and cell class (v2) | 9.71e-06 | 154 | 82 | 5 | e080d5104fe6f3f6ef617bbcdccf1332ab7231e1 | |
| ToppCell | Adult-Mesenchymal-vascular_smooth_muscle_cell-D122|Adult / Lineage, Cell type, age group and donor | 1.17e-05 | 160 | 82 | 5 | fd14dfeb7021a4b7299371854dc8fc1fd66c8dae | |
| ToppCell | droplet-Lung-21m-Hematologic-myeloid-classical_monocyte-classical_monocyte_l15|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.36e-05 | 165 | 82 | 5 | 94a5211072464fc24592bb107a853ce832e816fe | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_B-B_cell-B_c01-TCL1A|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.48e-05 | 168 | 82 | 5 | 9a8709d34865cfa668d8f3335dc34fc86fc32482 | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-Pecam____kidney_capillary_endothelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.52e-05 | 169 | 82 | 5 | 87116c33c5ca8cb1862e103e5607b1df4d264569 | |
| ToppCell | COVID-19-Heart-VSMC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.80e-05 | 175 | 82 | 5 | 1125f0d3a5b2388fa77a820dea0288e824d84a82 | |
| ToppCell | wk_15-18-Hematologic-Meg-ery-Definitive_erythrocyte|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.85e-05 | 176 | 82 | 5 | 9af82b976e6a14a3ef7aa50f1f7af2463e5aa5d2 | |
| ToppCell | 5'-GW_trimst-2-LymphNode-Hematopoietic-Red_blood_cells|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.12e-05 | 181 | 82 | 5 | 577bf37a6594fad01251d2c66d8ccda8e949b6cf | |
| ToppCell | 5'-GW_trimst-2-LymphNode-Hematopoietic-Red_blood_cells-RBC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.12e-05 | 181 | 82 | 5 | f5dc7a650afe8837cb424981e50ad2c8b18c7c32 | |
| ToppCell | Adult-Epithelial-ciliated_cell-D122|Adult / Lineage, Cell type, age group and donor | 2.17e-05 | 182 | 82 | 5 | 7ded554a4b441e6496db673ba206c0d76ccad7d9 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-4|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 2.29e-05 | 184 | 82 | 5 | 67164bb6bcae7322cb89b585c7aa10bce35b0ecd | |
| ToppCell | 10x5'v1-week_17-19-Hematopoietic-erythroid-mid_erythroid|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.35e-05 | 185 | 82 | 5 | e9059cefcdf0972ec90793b1dd34c3292b17a061 | |
| ToppCell | NS-moderate-d_16-33-Epithelial-Ciliated|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.35e-05 | 185 | 82 | 5 | 5e689c2fb36ce3ac2adc8d15f67107f21cf68868 | |
| ToppCell | IIF-Other|IIF / Disease, Lineage and Cell Type | 2.48e-05 | 187 | 82 | 5 | ae44d9261698cc0289750a546baf050f78b119b3 | |
| ToppCell | Ciliated_cells-B-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 2.48e-05 | 187 | 82 | 5 | 2b4262c2e7c7830a976be168cee6eeb738d4feda | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-hematologic-erythrocytic-erythrocyte|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.48e-05 | 187 | 82 | 5 | c4ba9dfedbcf0357a8627af03f4fe1770e985a03 | |
| ToppCell | COVID-19-Fibroblasts-Airway_smooth_muscle|COVID-19 / group, cell type (main and fine annotations) | 2.48e-05 | 187 | 82 | 5 | 464a0c3b92b778911b5f9cd73642e09e3472063a | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-hematologic-erythrocytic|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.48e-05 | 187 | 82 | 5 | 13023661c26aaf9e42262a4ff91f2fb26e8a3eaf | |
| ToppCell | facs-Heart-LA-18m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.48e-05 | 187 | 82 | 5 | f1e9877d859369b862d4a559ec9ab9be74a67a96 | |
| ToppCell | facs-Heart-LA-18m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.48e-05 | 187 | 82 | 5 | 3ffbd50b49059dcd3e23c5ac01901e4352142446 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.48e-05 | 187 | 82 | 5 | 73931a5ea73799095daff100b5f18853c57c74dc | |
| ToppCell | 10x_3'_v3-blood_(10x_3'_v3)-hematologic-erythrocytic-erythrocyte|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.54e-05 | 188 | 82 | 5 | da211e7fb62fff176aa9c39061aef9ab0af6079e | |
| ToppCell | 10x_3'_v3-blood_(10x_3'_v3)-hematologic|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.54e-05 | 188 | 82 | 5 | 3c6c0eaadc474ebb218ae349b787c410f66177ab | |
| ToppCell | 10x_3'_v3-blood_(10x_3'_v3)-hematologic-erythrocytic|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.54e-05 | 188 | 82 | 5 | 3467149de45b47a5015486ef94bec070e9c3ffc2 | |
| ToppCell | (7)_Epithelial-F_(Ciliated)|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 2.54e-05 | 188 | 82 | 5 | 9a8b9f745eed9f129b6c582f48fbbaaacbebb4b3 | |
| ToppCell | Adult-Epithelial-ciliated_cell|Adult / Lineage, Cell type, age group and donor | 2.60e-05 | 189 | 82 | 5 | b679920f0993e917dd86da082113bfbd85ea1ca5 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-vascular_smooth_muscle_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.67e-05 | 190 | 82 | 5 | d6b3a92119b210974a32af3fe9875d60eb02761e | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.74e-05 | 191 | 82 | 5 | 04c4d454b57e29a8d1dcdeb4678ce71bdc29b77b | |
| ToppCell | Megakaryocytic-erythropoietic-Erythro-cells-Erythrocyte|Megakaryocytic-erythropoietic / Lineage, cell class and subclass | 2.95e-05 | 194 | 82 | 5 | f0ababe8daa57f6827a3e2e72c884d9e8b2687a3 | |
| ToppCell | COVID-19-lung-Pericytes/_Smooth_Muscle|lung / Disease (COVID-19 only), tissue and cell type | 2.95e-05 | 194 | 82 | 5 | 5e1e0513a54ec4cf0b247ec85c9fbc68dfac1da3 | |
| ToppCell | COVID-19-T_cells-Cycling_NK/T_cells|COVID-19 / group, cell type (main and fine annotations) | 3.02e-05 | 195 | 82 | 5 | 764ed100c28d9bc93ee5ecabc5291c8f184d78da | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.02e-05 | 195 | 82 | 5 | 79dc031258579ea328181dda33710dd897f1064a | |
| ToppCell | moderate-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 3.02e-05 | 195 | 82 | 5 | 3486eae5fdb062a75a907b896c9d7b396d2aa195 | |
| ToppCell | COVID-19-Epithelial-Ciliated_cells|Epithelial / Condition, Lineage and Cell class | 3.10e-05 | 196 | 82 | 5 | de7aa31354b019d7321a8ef965d59ce2e8b89276 | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-Ciliated|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.10e-05 | 196 | 82 | 5 | 686a5a0ddb00929842c1c98445c59edfcc9a8a04 | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-Ciliated-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.10e-05 | 196 | 82 | 5 | 67aefc480714e4b8c9ae53c036efdc07ec6f94af | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-Ciliated|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.10e-05 | 196 | 82 | 5 | ca56311edc6788e032e7635fa69b1e07035202b5 | |
| ToppCell | Severe_COVID-19-Epithelial-Ciliated|Severe_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 3.10e-05 | 196 | 82 | 5 | 1cdef976a754c90d18b6149d367bd64e6e99b0a9 | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-Ciliated-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.10e-05 | 196 | 82 | 5 | 69f5081e06d84ec1d9695762df801a9d0df1984b | |
| ToppCell | COVID-19-Heart-Mito_CM|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.18e-05 | 197 | 82 | 5 | 44e49943d62bfe622b40ad0460093d31540544df | |
| ToppCell | Bronchial-NucSeq-Stromal-Myofibroblastic-Muscle_perivascular_immune_recruiting|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.18e-05 | 197 | 82 | 5 | cfb3dc4b401800e33c82cfc3baee69dbbd16ac8c | |
| ToppCell | NS-moderate-d_0-4-Epithelial-Ciliated|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.18e-05 | 197 | 82 | 5 | 71fea4aa6ce96c7693fa94792d08770622873850 | |
| ToppCell | control-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 3.18e-05 | 197 | 82 | 5 | e453d085182364ca347cbcc9dc995c62c3353016 | |
| ToppCell | Fibroblast|World / shred by cell class for bronchial biopsy | 3.18e-05 | 197 | 82 | 5 | 8bf9846228b6b6721b10375fe54a2fb389ff64a6 | |
| ToppCell | control-Epithelial-Ciliated|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 3.18e-05 | 197 | 82 | 5 | d4e963c1f82996371bf3d63578ee9fce8e00c5a8 | |
| ToppCell | Tracheal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.18e-05 | 197 | 82 | 5 | ac4f53acb2f8a428b0f2fab3c30a34e095a1bed7 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_ciliated-Deuterosomal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.25e-05 | 198 | 82 | 5 | f31790442ef142f1c0c49bf3daf2d0efb193d2c9 | |
| ToppCell | critical-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 3.25e-05 | 198 | 82 | 5 | ee2c8385c0bf4ea9f5c9517b52cf131af3fbdd40 | |
| ToppCell | Tracheal-10x5prime-Stromal-Myofibroblastic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.33e-05 | 199 | 82 | 5 | 0a145172787f40d0fdaf21188d539ffaf7ece3e4 | |
| ToppCell | distal-1-Epithelial-Ciliated|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.33e-05 | 199 | 82 | 5 | 4120e4a2bc05adebe1e1e9670ed7ea55142eb83d | |
| ToppCell | Bronchus_Control_(B.)-Stromal-TX-Smooth_muscle-2|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 3.33e-05 | 199 | 82 | 5 | 2c5ad62919c64ea0242e0984bb9932d2d975f4e3 | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_airway_ciliated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.41e-05 | 200 | 82 | 5 | 52aef65f01b06cd98056f17977efe525aee6eb6f | |
| ToppCell | Lung_Parenchyma-Severe-Hematopoietic-RBC-RBC|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.41e-05 | 200 | 82 | 5 | b5f2892bc45fda5ae05e269b840305a608a07c37 | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_airway_ciliated-Ciliated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.41e-05 | 200 | 82 | 5 | 55c148238d5c80c1faa3428a917ae8075be2c145 | |
| ToppCell | LPS_anti-TNF-Hematopoietic_Myeloid-Dendritic_cells-pDC|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.41e-05 | 200 | 82 | 5 | 6a34e07e6d77fe3fdd9ff44c4b1e46a023f6d6a2 | |
| ToppCell | Lung_Parenchyma-Severe-Hematopoietic-RBC|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.41e-05 | 200 | 82 | 5 | 9ce1f91991637fc3af0f6a80a85e1a44276fe412 | |
| ToppCell | Bronchus_Control_(B.)-Epithelial-TX-Ciliated|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 3.41e-05 | 200 | 82 | 5 | 6a2ccc71a0cbe04a542c379b28b5006de53981c3 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_ciliated-Ciliated|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.41e-05 | 200 | 82 | 5 | af6a551f83808c1c839df7ba7b1702ca28ea6e1b | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_airway_ciliated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.41e-05 | 200 | 82 | 5 | 85c98da55f7cd4ffdf9d309b56c8cc5d43f3c04c | |
| ToppCell | Lung_Parenchyma-Severe-Hematopoietic|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.41e-05 | 200 | 82 | 5 | fdf3e60cf94f398a56c0fa72813d0459f5ce081b | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_ciliated|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.41e-05 | 200 | 82 | 5 | 73ac1cf40ddd764be1100cbfaaa29563665457d8 | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_airway_ciliated-Ciliated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.41e-05 | 200 | 82 | 5 | 12bc7d95c4166d12487081a76d210b7abe5991b0 | |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial-Ciliated|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.41e-05 | 200 | 82 | 5 | ddd39b754bfaa98249d497dfb7e97ec58617a11a | |
| ToppCell | Lung_Parenchyma-Severe-Hematopoietic-RBC-RBC-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.41e-05 | 200 | 82 | 5 | 199165be1aef8497af71b74690a11de18fbe073c | |
| ToppCell | Parenchyma_Control_(B.)-Epithelial-TX-Ciliated|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 3.41e-05 | 200 | 82 | 5 | a521cf837cadf280505ff9d7e641a205af7d6513 | |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial-Ciliated-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.41e-05 | 200 | 82 | 5 | 918b576fd9491d23c2bb9d663fa5fb3505cb1c7e | |
| ToppCell | Parenchyma_COVID-19-Stromal-TX-Erythrocytes|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 3.41e-05 | 200 | 82 | 5 | a9edac2f5e009662df452ec032a80e855cdac28f | |
| ToppCell | MS-IIF-Others|IIF / Disease, condition lineage and cell class | 3.41e-05 | 200 | 82 | 5 | e585ac220594f860f2fa7036bb23b165e2d74a41 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L6_IT-L6_IT_VISp_Car3|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.10e-04 | 134 | 82 | 4 | 4ef5f395e321cf04e56560be2502a8aa157682f4 | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Rectal_Adenocarcinoma-2|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 1.37e-04 | 142 | 82 | 4 | 959af19add016f21c814c28604d0177b88ebed12 | |
| ToppCell | Megakaryocytic-erythropoietic-Erythro-cells-Erythrocyte|Erythro-cells / Lineage, cell class and subclass | 1.45e-04 | 144 | 82 | 4 | 7fbedc65314cfb06bcc527d794b5de7858f7c5ec | |
| ToppCell | 10x5'v1-week_12-13-Hematopoietic-erythroid-late_erythroid|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.45e-04 | 144 | 82 | 4 | ca365380ccf5e60d2e3f6272059ff0531759612d | |
| ToppCell | Healthy_donor-RBC|World / disease group, cell group and cell class (v2) | 1.70e-04 | 150 | 82 | 4 | 1e1a497ec4b048f7e9cc12dd5dd9aba7fedca9e1 | |
| ToppCell | TCGA-Thymus-Primary_Tumor-Thymoma-Type_AB-8|TCGA-Thymus / Sample_Type by Project: Shred V9 | 1.74e-04 | 151 | 82 | 4 | 5906562efd36fbcb91f96e0a0d3a8fe999ba1e79 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.78e-04 | 152 | 82 | 4 | bd1f36b436d8ab7dd8420f595b97d851eab31a38 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.78e-04 | 152 | 82 | 4 | ee329249a034a969a16b26a224aa04249d67382d | |
| ToppCell | Adult-Immune-enucleated_erythrocyte|Adult / Lineage, Cell type, age group and donor | 1.92e-04 | 155 | 82 | 4 | e2d07ee4348d2c1d3552a8d0337ea42777c31f9c | |
| ToppCell | facs-Brain_Myeloid-Striatum_-18m-Myeloid-macrophage|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.02e-04 | 157 | 82 | 4 | 9d4308312301cb922f156a7b6aededc9e1c62807 | |
| ToppCell | AT1-AT2_cells-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 2.07e-04 | 158 | 82 | 4 | 3bc51cfd37b289cc3e866b54ce55a298e5eff690 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-vascular_smooth_muscle_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.33e-04 | 163 | 82 | 4 | 8f24cef152f5965727bbeee116bd26c75cbba82a | |
| ToppCell | 3'_v3-Lung-Hematopoietic_progenitors-Cycling_pre-Myeloid-2|Lung / Manually curated celltypes from each tissue | 2.33e-04 | 163 | 82 | 4 | 47300dec94dc66e965bf71fafff0a9fd24fae968 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-FOXM1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.33e-04 | 163 | 82 | 4 | 5285318c52aa31c9b22dc2ffff078e32e408604d | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-vascular_smooth_muscle_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.33e-04 | 163 | 82 | 4 | 51dee6c21cbeca4e17d1cc386e203f0c403089e8 | |
| ToppCell | droplet-Fat-Mat-18m-Myeloid-monocyte|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.39e-04 | 164 | 82 | 4 | a27b9b3380f29bb17c9f787423f2591f2b9cf33e | |
| ToppCell | Adult-Immune-interstitial_macrophage_(C1Q_positive)-D122|Adult / Lineage, Cell type, age group and donor | 2.50e-04 | 166 | 82 | 4 | be284e2e596390f05305c7bcfc316f87b963fc0b | |
| ToppCell | E16.5-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated-Ciliated_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.61e-04 | 168 | 82 | 4 | fa7c0303918cea04e3f4c4f3cb079be19004d214 | |
| ToppCell | E16.5-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.61e-04 | 168 | 82 | 4 | 7edcab103c69e928d5c19a0d218ffb3ae32f9e70 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.67e-04 | 169 | 82 | 4 | fba841664939c771881ba97f14ef1df6635c04ff | |
| Disease | congenital muscular dystrophy (implicated_via_orthology) | 1.05e-04 | 6 | 79 | 2 | DOID:0050557 (implicated_via_orthology) | |
| Disease | alcohol-related neurodevelopmental disorder (implicated_via_orthology) | 1.96e-04 | 8 | 79 | 2 | DOID:0050667 (implicated_via_orthology) | |
| Disease | Global developmental delay | 4.56e-04 | 133 | 79 | 4 | C0557874 | |
| Disease | response to radiation, Urinary retention | 9.38e-04 | 17 | 79 | 2 | GO_0009314, HP_0000016 | |
| Disease | Joubert syndrome 1 | 1.44e-03 | 21 | 79 | 2 | C4551568 | |
| Disease | mean platelet volume | 1.60e-03 | 1020 | 79 | 9 | EFO_0004584 | |
| Disease | Sarcosine measurement | 1.73e-03 | 23 | 79 | 2 | EFO_0021668 | |
| Disease | mental development measurement | 2.04e-03 | 25 | 79 | 2 | EFO_0008230 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LSDHEQRELYEAARL | 1516 | Q9Y6Y1 | |
| LSAYEAELEARLNLR | 701 | Q7Z7A1 | |
| ILRLDLAGRDLTDYL | 176 | Q562R1 | |
| YRLADLLEENQEELA | 511 | Q3SY69 | |
| ENALLEAQDVELYLR | 326 | Q96DT5 | |
| KLRLEEEALYAAQRE | 101 | Q63HQ0 | |
| EGLRTLAIAYRDLDD | 591 | Q8TF62 | |
| QERLDRLLYVQELLE | 321 | Q9H9F9 | |
| LDDALVRQDAQDLYE | 166 | P09525 | |
| LALYDSLRAEFDQLR | 486 | Q8TF21 | |
| YDVLDESLRRAELNH | 296 | Q9UPM8 | |
| DDKLYQRDLEVALAL | 91 | Q96B01 | |
| LELADYEAENLARLQ | 146 | P49758 | |
| ALRSFDYEQLRDLQL | 516 | Q9Y5G8 | |
| LLNELDRSLGRYRDE | 256 | Q86T65 | |
| ELEDNYLEYLREARR | 546 | Q8N612 | |
| ALRSFDYEQLRDLQL | 516 | Q9Y5G7 | |
| LLILLEAAEYLERRD | 6 | Q14582 | |
| YEDALIDEVERALRL | 391 | Q8N7X4 | |
| LLRLAEALAFRQDLE | 1501 | Q8N201 | |
| YRDLKLDNVLLDRDG | 471 | Q05655 | |
| RELYLEEALQNERDL | 271 | Q9NTX5 | |
| AEDYRELERLALQAE | 56 | Q9H427 | |
| LLDVIRAENDRDIYL | 76 | Q8TD08 | |
| LNDALDRLEELREFA | 7166 | Q03001 | |
| LYETELADARRALDD | 81 | P20700 | |
| CYDVRNLIDLDDQRR | 256 | Q9P1W3 | |
| VYRDLLNRGLEDQLL | 286 | Q9Y664 | |
| AYEELLNQRRLEEDR | 246 | Q1MSJ5 | |
| ERDYLLERRDLAVDF | 111 | O94915 | |
| AYVDLDERAIDALRE | 56 | O43390 | |
| RIYLDERRDVLDDLV | 186 | Q9NRD0 | |
| DSTLEAQYRRLLELD | 446 | Q7L591 | |
| DDEIYSLRIIDLIDR | 891 | P50748 | |
| RLFDLRADQELLLYS | 251 | Q9HAV0 | |
| EELDLLRIDRNRYLN | 141 | Q96M63 | |
| VLDDVELREAQRDYL | 6 | P25205 | |
| ELREAQRDYLDFLDD | 11 | P25205 | |
| LDRALDYEQEAELRL | 196 | Q9Y5E9 | |
| AEYFDESLVLLRRLL | 241 | Q96A11 | |
| LEVNRRLLDLDEAAY | 646 | Q14393 | |
| EEELRNLRLEYDDLR | 1721 | P15924 | |
| LRLNLLDLDYELAEQ | 2006 | P12111 | |
| DVLRRELALECDYQR | 396 | Q8NI60 | |
| DLERRNEELEELYLL | 61 | Q6TDU7 | |
| LQVLEERDLELERYD | 61 | Q2TAC2 | |
| LRLDEALRLYLEAFR | 776 | Q92538 | |
| VALDYVLDADTDRRL | 566 | Q13683 | |
| LEELQSLRELDLYDN | 116 | Q15435 | |
| YRRLGEEALSLQALD | 501 | Q8IZD6 | |
| YNNLLALGTERRLDE | 1171 | O75334 | |
| DLAELELLYLDRNSI | 276 | Q9GZU5 | |
| ARLELADYEAESLAR | 141 | P49802 | |
| ELELRHENYDEALRL | 441 | Q9HCS7 | |
| HEYRLLARLEELDLA | 196 | P14373 | |
| EVENYEALLNLAERL | 416 | Q9H0F5 | |
| EERLADLASDLLLQY | 321 | O15240 | |
| RYERLEEQLNDLTEL | 561 | O75069 | |
| LYEDEVRELEEALRR | 201 | O15061 | |
| LESENDEYERARRLL | 651 | O94906 | |
| FLDYQLDELSRQRAL | 2086 | Q7Z333 | |
| LLRELEETRDLNYLL | 126 | Q6ZUB1 | |
| LEAREDLAALERDYE | 426 | A6NHL2 | |
| ELLRLYLNYDLLEEA | 1336 | Q12769 | |
| DQLDLRRDIAYNLSL | 851 | Q9Y5Q9 | |
| FRLENDLEELALYQI | 301 | Q13057 | |
| LEELNERYRLDCNLA | 161 | Q5JTD0 | |
| ELVEAELFARYDRLL | 281 | Q9UBS8 | |
| DLEYLQADFNLLRDI | 131 | Q96PX8 | |
| LYLRIDLERLQCLNE | 31 | Q9GZP4 | |
| DDLLAAADKYALERL | 271 | O43791 | |
| LESLYRDIRDIQDEN | 41 | O75558 | |
| YRLREAQDRARAEDL | 161 | Q9Y3Q3 | |
| DQLLDRYRELQLSTE | 436 | Q8WXW3 | |
| RRLDIVRSLYEDLED | 176 | P40337 | |
| ERYRCERLEEQLNDL | 501 | O94876 | |
| EAEYRRELALRNELI | 401 | P11277 | |
| LLLENYEEYAARARL | 136 | Q16763 | |
| IRAYRDDIDLQNLID | 131 | P62079 | |
| ELNLRSLETYERLEA | 181 | Q15906 | |
| ILIADLNELRYQRED | 196 | Q2TAA8 | |
| LEAAYLDLQRILENE | 71 | O75347 | |
| LLNEFSRLEERYDDL | 1081 | Q9Y4I1 |